{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:39:26Z","timestamp":1791405566068,"version":"4.3.3"},"reference-count":38,"publisher":"BMJ","issue":"8","license":[{"start":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T00:00:00Z","timestamp":1628553600000},"content-version":"unspecified","delay-in-days":9,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81970025"],"award-info":[{"award-number":["81970025"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2021,6,9]]},"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Asthma often coexists with gastro-oesophageal reflux disease (GERD). The effect of proton pump inhibitors (PPIs) treatment on asthma concomitant with GERD was inconsistent. This study aimed to assess whether PPIs treatment improved morning peak expiratory flow (mPEF) in asthma patients with GERD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Data sources<\/jats:title><jats:p>PubMed, MEDLINE, EMBASE, Web of Science, Cochrane Library and ClinicalTrials.gov; hand searching for reference lists; contacted with authors if necessary.<\/jats:p><\/jats:sec><jats:sec><jats:title>Study selection<\/jats:title><jats:p>All eligible trials were randomised clinical trials comparing PPIs with placebo in asthma patients accompanying with GERD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Fourteen randomised clinical trials (2182 participants) were included. Overall, PPIs versus placebo did not affect mPEF in patients with asthma having GERD (weighted mean difference 8.68\u2009L\/min, 95% CI \u22122.02 to 19.37, p=0.11). Trial sequential analysis (TSA) further confirmed this finding (TSA adjusted 95%\u2009CI \u22121.03 to 22.25). Subgroups analyses based on the percentage of patients with symptomatic GERD\u226595%, treatment duration &gt;12 weeks also found no statistically significant benefit on mPEF. Similarly, analyses of secondary outcomes (evening PEF, forced expiratory volume in 1\u2009s, asthma symptoms score, asthma quality of life score and episodes of asthma exacerbation) did not show significant difference between PPIs and placebo.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In this meta-analysis, PPIs therapy did not show a statistically significant improvement on mPEF in asthma patients having GERD, neither in subgroup with symptomatic GERD nor in subgroup with treatment duration &gt;12 weeks. This analysis does not support a recommendation for PPIs therapy as empirical treatment in asthma patients with GERD.<\/jats:p><\/jats:sec><jats:sec><jats:title>PROSPERO registration number<\/jats:title><jats:p>CRD42020177330.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjopen-2020-043860","type":"journal-article","created":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T17:34:39Z","timestamp":1628616879000},"page":"e043860","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":24,"title":["Randomised trials of proton pump inhibitors for gastro-oesophageal reflux disease in patients with asthma: an updated systematic review and meta-analysis"],"prefix":"10.1136","volume":"11","author":[{"given":"Zhoude","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1044-5284","authenticated-orcid":false,"given":"Jinming","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,8,10]]},"reference":[{"key":"2024112509061331000_11.8.e043860.1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m234"},{"key":"2024112509061331000_11.8.e043860.2","unstructured":"Global Initiative for Asthma . Global strategy for asthma management and prevention, 2019. Available: www.ginasthma. org"},{"key":"2024112509061331000_11.8.e043860.3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00630.x"},{"key":"2024112509061331000_11.8.e043860.4","doi-asserted-by":"publisher","DOI":"10.1378\/chest.126.5.1490"},{"key":"2024112509061331000_11.8.e043860.5","doi-asserted-by":"crossref","first-page":"282","DOI":"10.4103\/0022-3859.138754","article-title":"Prevalence of gastro-esophageal reflux disease in patients with difficult to control asthma and effect of proton pump inhibitor therapy on asthma symptoms, reflux symptoms, pulmonary function and requirement for asthma medications","volume":"60","author":"Sandur","year":"2014","journal-title":"J Postgrad Med"},{"key":"2024112509061331000_11.8.e043860.6","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/apt.14416","article-title":"Review article: gastro-oesophageal reflux disease in asthma and chronic obstructive pulmonary disease","volume":"47","author":"Broers","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"2024112509061331000_11.8.e043860.7","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0091-6749(99)70360-X","article-title":"Gastroesophageal reflux and asthma: insight into the association\u2606\u2606\u2606\u2605","volume":"104","author":"Harding","year":"1999","journal-title":"J Allergy and Immunol"},{"key":"2024112509061331000_11.8.e043860.8","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200110-033OC"},{"key":"2024112509061331000_11.8.e043860.9","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1053\/j.gastro.2017.07.049","article-title":"Management of gastroesophageal reflux disease","volume":"154","author":"Gyawali","year":"2018","journal-title":"Gastroenterology"},{"key":"2024112509061331000_11.8.e043860.10","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.70.823.350"},{"key":"2024112509061331000_11.8.e043860.11","doi-asserted-by":"publisher","DOI":"10.1007\/BF02090360"},{"key":"2024112509061331000_11.8.e043860.12","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1445-5994.1996.tb02938.x","article-title":"Adult asthma and gastro-oesophageal reflux: the effects of omeprazole therapy on asthma","volume":"26","author":"Teichtahl","year":"1996","journal-title":"Aust N Z J Med"},{"key":"2024112509061331000_11.8.e043860.13","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.98.11051070"},{"key":"2024112509061331000_11.8.e043860.14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.329_q.x"},{"key":"2024112509061331000_11.8.e043860.15","doi-asserted-by":"publisher","DOI":"10.1378\/chest.116.5.1257"},{"key":"2024112509061331000_11.8.e043860.16","doi-asserted-by":"publisher","DOI":"10.1378\/chest.128.3.1128"},{"key":"2024112509061331000_11.8.e043860.17","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2004.068890"},{"key":"2024112509061331000_11.8.e043860.18","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200507-1167OC"},{"key":"2024112509061331000_11.8.e043860.19","first-page":"119","article-title":"Evaluation of pantoprazol treatment response of patients with asthma and gastroesophageal reflux: a randomized prospective double-blind placebo-controlled study","volume":"33","author":"dos Santos","year":"2007","journal-title":"J Bras Pneumol"},{"key":"2024112509061331000_11.8.e043860.20","doi-asserted-by":"crossref","first-page":"169","DOI":"10.13181\/mji.v17i3.317","article-title":"Asthma symptoms improvement in moderate persistent asthma patients with gastroesophageal reflux disease (GERD): the role of proton-pump inhibitor","volume":"17","author":"Susanto","year":"2008","journal-title":"Medical Journal of Indonesia"},{"key":"2024112509061331000_11.8.e043860.21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0806290"},{"key":"2024112509061331000_11.8.e043860.22","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200910-1537OC"},{"key":"2024112509061331000_11.8.e043860.23","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.2035"},{"key":"2024112509061331000_11.8.e043860.24","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.56.3.198"},{"key":"2024112509061331000_11.8.e043860.25","first-page":"Cd001496","article-title":"Gastro-Oesophageal reflux treatment for asthma in adults and children","volume":"2","author":"Gibson","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"2024112509061331000_11.8.e043860.26","first-page":"1","article-title":"Does treatment with proton pump inhibitors for gastroesophageal reflux disease (GERD) improve asthma symptoms in children with asthma and GERD? A systematic review","volume":"19","author":"Sopo","year":"2009","journal-title":"J Investig Allergol Clin Immunol"},{"key":"2024112509061331000_11.8.e043860.27","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2011.116"},{"key":"2024112509061331000_11.8.e043860.28","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"2024112509061331000_11.8.e043860.29","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3003.1999.14a06.x"},{"key":"2024112509061331000_11.8.e043860.30","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200801-060ST"},{"key":"2024112509061331000_11.8.e043860.31","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-013-0101-8"},{"key":"2024112509061331000_11.8.e043860.32","doi-asserted-by":"publisher","DOI":"10.1586\/17474124.2015.1042861"},{"key":"2024112509061331000_11.8.e043860.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2008.05.022"},{"key":"2024112509061331000_11.8.e043860.34","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e3182a6589b"},{"key":"2024112509061331000_11.8.e043860.35","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-008-0396-6"},{"key":"2024112509061331000_11.8.e043860.36","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v13.i11.1706"},{"key":"2024112509061331000_11.8.e043860.37","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejcdt.2013.10.014","article-title":"Combination therapy versus monotherapy for gastroesophageal reflux in children with difficult-to-treat bronchial asthma","volume":"63","author":"Bediwy","year":"2014","journal-title":"Egypt J Chest Dis Tuberc"},{"key":"2024112509061331000_11.8.e043860.38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cct.2019.01.009","article-title":"Genotype tailored treatment of mild symptomatic acid reflux in children with uncontrolled asthma (GenARA): rationale and methods","volume":"78","author":"Tang","year":"2019","journal-title":"Contemp Clin Trials"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2020-043860","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T17:08:38Z","timestamp":1732554518000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2020-043860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":38,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8,10]]},"published-print":{"date-parts":[[2021,8]]}},"alternative-id":["10.1136\/bmjopen-2020-043860"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2020-043860","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8]]}}}